scout
|Videos|September 27, 2016

Special Reports

  • Hematologic Malignancies: Polycythemia Vera
  • Volume 3
  • Issue 3

Significant Developments in Treating PV

Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, discusses the most recent developments in diagnosing polycythemia vera.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME